Tue, February 18, 2020

David Amsellem Initiated (XERS) at Buy and Held Target at $12 on, Feb 18th, 2020

David Amsellem of Piper Sandler, Initiated "Xeris Biopharma Holdings, Inc." (XERS) at Buy and Held Target at $12 on, Feb 18th, 2020.

David, nor any peers, have made any analyst calls on XERS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30